Tracking differential gene expression in MRL/MpJ versus C575BL/6 anergic B cells: Molecular markers of autoimmunity

Biomarker Insights

Volumn 2008, Issue 3, 2008, Pages 335-350

  Clark, Amy G ^a   Mackin, Katherine M ^a   Foster, Mary H ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Anergy; Autoimmunity; B cell; Birc1f (Naip); CD74; Estrogen; Mef2c; Ptpn22

Indexed keywords

ALPHA CARDIAC ACTIN; ANTIGEN; CD74 ANTIGEN; CELL CYCLE PROTEIN; CELL DIVISION CYCLE 2 HOMOLOG A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; ESTRADIOL; GAMMA 2 SMOOTH MUSCLE ACTIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KARYOPHERIN ALPHA; KARYOPHERIN ALPHA 2; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE P38; MOLECULAR MARKER; MYOCYTE ENHANCER FACTOR 2; NEURONAL APOPTOSIS INHIBITORY PROTEIN; NEURONAL APOPTOSIS INHIBITORY PROTEIN 1F; NUCLEOPORIN; NUCLEOPORIN 153; PROTEIN KINASE INHIBITOR; PROTEIN KINASE INHIBITOR BETA; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 22; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA PROTEIN 1; SMOOTH MUSCLE ACTIN; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE;

ANIMAL CELL; ANTIGEN PURIFICATION; APOPTOSIS; ARTICLE; AUTOIMMUNITY; C57BL 6 MOUSE; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL ISOLATION; CELL MATURATION; CELL PROLIFERATION; CLONAL ANERGY; CONTROLLED STUDY; DNA MICROARRAY; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE TARGETING; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; IMMUNOGENETICS; MOUSE; MOUSE STRAIN; MRL MPJ MOUSE; NONHUMAN; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STRAIN DIFFERENCE; TRANSGENE;

MUS;

EID: 47749156454     PISSN: None     EISSN: 11772719     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. Abrahamson, D.R., Prettyman, A.C., Robert, B. and St John, P.L. 2003. Laminin-1 reexpression in Alport mouse glomerular basement membranes. Kidney Int., 63(3):826-34.
2. Allam, A. and Marshall, A.J. 2005. Role of the adaptor proteins Bam32, TAPP1 and TAPP2 in lymphocyte activation. Immunol. Lett., 97(1):7-17.
3. Amital, H., Heilweil, M., Ulmansky, R., Szafer, F., Bar-Tana, R., Morel, L., Foster, M.H., Mostoslavsky, G., Eilat, D., Pizov, G. and others. 2005. Treatment with a laminin-derived peptide suppresses lupus nephritis. J. Immunol., 175(8):5516-23.
4. Amital, H., Heilweil-Harel, M., Ulmansky, R., Harlev, M., Toubi, E., Hershko, A. and Naparstek, Y. 2007. Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption. Rheumatology (Oxford), 46(9):1433-7.
5. Andrews, B.S., Eisenberg, R.A., Theofilopoulos, A.N., Izui, S., Wilson, C.B., McConahey, P.J., Murphy, E.D., Roths, J.B. and Dixon, F.J. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med., 148:1198-215.
6. Apelgren, L.D., Bailey, D.L., Fouts, R.L., Short L., Bryan, N., Evans, G.F., Sandusky, G.E., Zuckerman, S.H., Glasebrook A. and Bumol, T.F. 1996. The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice. Cell. Immunol., 173(1):55-63.
7. Ball, J.R. and Ullman, K.S. 2005. Versatility at the nuclear pore complex: lessons learned from the nucleoporin Nup153. Chromosoma., 114(5):319-30.
8. Becker-Herman, S., Arie, G., Medvedovsky, H., Kerem, A. and Shachar, I. 2005. CD74 is a member of the regulated intramembrane proteolysis-processed protein family. Mol. Biol. Cell., 16(11):5061-9.
9. Begovich, A.B., Carlton, V.E., Honigberg, L.A., Schrodi, S.J., Chokkalingam, A.P., Alexander, H.C., Ardlie, K.G., Huang, Q., Smith, A.M., Spoerke, J.M. and others,. 2004. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN.22) is associated with rheumatoid arthritis. Am. J. Hum. Genet., 75(2):330-7.
10. Benlagha, K., Park, S.H., Guinamard, R., Forestier, C., Karlsson, L., Chang, C.H. and Bendelac, A. 2004. Mechanisms governing B cell developmental defects in invariant chain-deficient mice. J. Immunol., 172(4):2076-83.
11. Bilancio, A., Okkenhaug, K., Camps, M., Emery, J.L., Ruckle, T., Rommel, C. and Vanhaesebroeck, B. 2006. Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. Blood, 107(2):642-50.
12. Bond, G.L. and Levine, A.J. 2007. A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans. Oncogene., 26(9):1317-23.
13. Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M., MacMurray, J., Meloni, G.F., Lucarelli, P., Pellecchia, M. and others. 2004. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet., 36(4):337-8.
14. Brady, G.F., Congdon, K.L., Clark, A.G., Sackey, F.N., Rudolph, E.H., Radic, M.Z. and Foster, M.H. 2004. Kappa editing rescues autoreactive B cells destined for deletion in mice transgenic for a dual specific anti-laminin Ig. J. Immunol., 172(9):5313-21.
15. Bynoe, M., Grimaldi, C. and Diamond, B. 2000. Estrogen up-regulates Bcl-2 and blocks tolerance induction of naive B cells. Proc. Natl. Acad. Sci. U.S.A., 97:2703-8.
16. Bynote, K.K., Hackenberg, J.M., Korach, K.S., Lubahn, D.B., Lane, P.H. and Gould, K.A. 2008. Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 mice. Genes Immun., 9(2):137-52.
17. Cambier, J.C., Gauld, S.B., Merrell, K.T. and Vilen, B.J. 2007. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nat. Rev. Immunol., 7(8):633-43.
18. Clark, A.G., Chen, S., Zhang, H., Brady, G.F., Ungewitter, E.K., Bradley, J.K., Sackey; F.N. and Foster, M.H. 2001. Multifunctional regulators of cell growth are differentially expressed in anergic murine B cells. Mol. Immunol., 44(6):1274-85.
19. Cloutier, J.F. and Veillette, A. 1999. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J. Exp. Med., 189(1):111-21.
20. Cohen, S., Dadi, H., Shaoul, E., Sharfe, N. and Roifman, C.M. 1999. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood, 93(6):2013-24.
21. Conrad, F.J., Rice, J.S. and Cambier, J.C. 2007. Multiple paths to loss of anergy and gain of autoimmunity. Autoimmunity, 40(6):419-24.
22. Criswell, L.A., Pfeiffer, K.A., Lum, R.F., Gonzales, B., Novitzke, J., Kern, M., Moser, K.L., Begovich, A.B., Carlton, V.E., Li, W. and others. 2005. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet., 76(4):561-71.
23. Dennis, G Jr., Sherman, B.T., Hosack, D.A., Yang, J., Gao, W., Lane, H.C. and Lempicki, R.A. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol., 4(5):3.
24. Ding, Z., Gillespie, L.L. and Paterno, G.D. 2003. Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain. Mol. Cell. Biol., 23(1):250-8.
25. Driggers, P.H., Segars, J.H. and Rubino, D.M. 2001. The proto-oncoprotein Brx activates estrogen receptor beta by a p38 mitogen-activated protein kinase pathway. J. Biol. Chem., 276(50):46792-7.
26. Duty, J.A., Szodoray, P., Zheng, N.-Y., Jared, M., Wilson, K. and Wilson, P.C. 2006. Analysis of a now autoreactive B cell population in human peripheral blood. 31st Annual Graduate Rresearch Education and Technolvy Symposium, University of Oklahoma Helath Sci. Ctr March:abstract 6 (p. 23)
27. Enarson, P., Rattner, J.B., Ou, Y., Miyachi, K., Horigome, T. and Fritzler, M.J. 2004. Autoantigens of the nuclear pore complex. J. Mol. Med., 82(7):423-33.
28. Esau, C., Does, M., Youn, H.D., Tatterson, L., Liu, J.O. and Chen, J. 2001. Deletion of calcineurin and myocyte enhancer factor 2 (MEF2) binding domain of Cabin1 results in enhanced cytokine gene expression in T cells. J. Exp. Med., 194(10):1449-59.
29. Foster, M.H. and Fitzsimons, M.M. 1998. Lupus-like nephrotropic autoantibodies in nonautoimmune mice harboring an anti-laminin Ig heavy chain transgene. Molecular Immunology, 35:83-94.
30. Foster, M.H., Zhang, Y. and Clark, A.G. 4006. Deconstructing B cell tolerance to basement membranes. Arch. Immunol. Ther. Exp., 54:1-11.
31. Garrett-Sinha, L.A., Hou, P., Wang, D., Grabiner, B., Araujo, E., Rao, S., Yun, T.J., Clark, E.A., Simon, M.C. and Clark, M.R. 2005. Spi-1 and Spi-B control the expression of the Grap2 gene in B cells. Gene., 353(1):134-46.
32. Glynne, R., Akkaraju, S., Healy, J.I., Rayner, J., Goodnow, C.C. and Mack, D.H. 2000a. How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis. Nature, 403:672-6.
33. Glynne, R., Ghandour, G., Rayner, J., Mack, D.H. and Goodnow, C.C. 2000b. B-lymphoryte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays. Immunol. Rev., 176:216-46.
34. Gore, Y., Starlets, D., Mahershak, N., Becker-Herman, S., Kaneyuki, U., Leng, L., Bucala, R. and Shachar, I. 2008. Macrophage Migration Inhibitory Factor Induces B Cell. Survival by Activation of a CD74-CD44 Receptor Complm J. Biol. Chem, 283(5):2784-92.
35. Gregersen, P.K., Lee, H.S., Batliwalla, F. and Begovich, A.B. 2006. PTPN22: setting thresholds for autoinummity. Semin. Immunol., 18(4):214-23.
36. Grimaldi, C.M., Cleary, J., Dagtas, A.S., Moussai, D. and Diamond, B. 2002. Estrogen alters thresholds for B cell apoptosis and activation. J. Clin. Invest., 109(12):1625-33.
37. Grimaldi, C.M., Jeganathan, V. and Diamond, B. 2006. Hormonal regulation of B cell development: 17 beta-estradiol impairs negative selection of high-affinity DNA-reactive B cells at more than one developmental checkpoint. J. Immunol., 176(5):2703-10.
38. Grimaldi, C.M., Michael, D.J. and Diamond, B. 2001. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol., 167(4):1886-90.
39. Hasegawa, K., Martin, F., Huang, G., Tumas, D., Diehl, L. and Chan, A.C. 2004. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science, 303(5658):685-9.
40. Hasegawa, K., Yajima, H., Katagiri, T., Ogimoto, M., Arimura, Y., Mitomo, K., Mashima, K., Mizuno, K. and Yakura, H. 1999. Requirement of PEST domain tyrosine phosphatase PEP in B cell antigen receptor-induced growth arrest and apoptosis. Eur. J. Immunol., 29(3):887-96.
41. Hecox, D.B. and Foster, M.H. 2004. Recent research developments in immunology: Regulation of humoral autoimmunity to basement membrane antigens. Research Signposts: Recent Res. Devel Immunology, 6:95-121.
42. Herkel, J., Mimran, A., Erez, N., Kam, N., Lohse, A.W., Marker-Hermann, E., Rotter, V. and Cohen, I.R. 2001. Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies. J. Autoimmun, 17(1):63-9.
43. Huang, X., Di Liberto, M., Cunningham, A.F., Kang, L., Cheng, S., Ely, S., Liou, H.C., Maclennan, I.C. and Chen-Kiang, S. 2004. Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G1/S transition in opposition to p181NK4c and p27Kip1. Proc. Natl. Acad. Sci. U.S.A., 101(51):17789-94.
44. Joseph, L.F., Ezhevsky, S. and Scott, D.W. 1995. Lymphoma models for B-cell activation and tolerance: anti-immunoglobulin M treatment induces growth arrest by preventing the formation ofan active kinase complex which phosphorylates retinoblastoma gene product in G1. Cell. Growth Differ, 6(1):51-7.
45. Kincade, P.W., Medina, K.L., Payne, K.J., Rossi, M.I., Tudor, K.S., Yamashita, Y. and Kouro, T. 2000. Early B-lymphocyte precursors and their regulation by sex steroids. Immunol. Rev., 175:128-37.
46. Kino, T., Souvatzoglou, E., Charmandari, E., Ichijo, T., Driggers, P., Mayers, C., Alatsatianos, A., Manoli, I., Westphal, H., Chrousos, G.P. and others. 2006. Rho family Guanine nucleotide exchange factor Brx couples extracellular signals to the glucocorticoid signaling system. J. Biol. Chem., 281(14):9118-26.
47. Kitaura, Y., Jang, I.K., Wang, Y., Han, Y.C., Inazu, T., Cadera, E.J., Schlissel, M., Hardy, R.R. and Gu, H. 2007. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity, 26(5):567-78.
48. Kumar, K.R., Li, L., Yan, R, Bhaskarabhatla, M., Mobley, A.B., Nguyen, C., Mooney, J.M., Schatzle, J.D., Wakeland, E.K. and Mohan, C. 2006. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science, 312(5780):1665-9.
49. Kussel, P. and Frasch, M. 1995. Pendulin, a Drosophila protein with cell cycle-dependent nuclear localization, is required for normal cell proliferation. J. Cell. Biol., 129(6):1491-507.
50. Kyogoku, C., Langefeld, C.D., Ortmann, W.A., Lee, A., Selby, S., Carlton, V.E., Chang, M., Ramos, P., Baechler, E.C., Batliwalla, F.M. and others. 2004. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet., 75(3):504-7.
51. Lantner, F., Starlets, D., Gore, Y., Flaishon, L., Yamit-Hezi, A., Dikstein, R., Leng, L., Bucala, R., Machluf, Y., Oren, M. and others. 2007. CD74 induces TAp63 expression leading to B-cell survival. Blood, 110(13):4303-11.
52. Lauwerys, B.R. and Wakeland, E.K. 2005. Genetics of lupus nephritis. Lupus, 14(1):2-12.
53. Lee, S.H. and McCormick, F. 2006. p97/DAP5 is a ribosome-associated factor that facilitates protein synthesis and cell proliferation by modulating the synthesis of cell cycle proteins. EMBO J., 25(17):4008-119.
54. Leng, L., Metz, C.N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R.A. and Bucala, R. 2003. MIF signal transduction initiated by binding to CD74. J. Exp. Med., 197(11):1467-76.
55. Li, L., Abdel Fattah, E., Cao, G., Ren, C., Yang, G., Goltsov, A.A., Chinault, A.C., Cai, W.W., Timme, T.L. and Thompson, T.C. 2008. Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling. Cancer Res., 68(2):434-43.
56. Li, L., Iwamoto, Y., Berezovskaya, A. and Boussiotis, V.A. 2006. A padyway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction ofT cell tolerance. Nat. Immunol., 7(11):1157-65.
57. Matsunaga, T., Ishida, T., Takekawa, M., Nishimura, S., Adachi, M. and Imai, K. 2002. Analysis of gene expression during maturation of immature dendritic cells derived from peripheral blood monocytes. Scand J. Immunol., 56(6):593-601.
58. Matza, D., Kerem, A., Medvedovsky, H., Lantner, F. and Shachar, I. 2002a. Invariant chain-induced B cell differentiation requires intramembrane proteolytic release of the cytosolic domain. Immunity, 17(5):549-60.
59. Matza, D., Lantner, F., Bogoch, Y., Flaishon, L., Hershkoviz, R. and Shachar, I. 2002b. Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity. Proc. Natl. Acad Sci. U.S.A., 99(5):3018-23.
60. Matza, D., Wolstein, O., Dikstein, R., and Shachar, I. 2001. Invariant chain induces B cell maturation by activating a TAF(II)105-NF-kappaB-dependent transcription program. J. Biol. Chem., 276(29):27203-6.
61. McGaha, T.L., Sorrentino, B. and Ravetch, J.V. 2005. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science, 307(5709):590-3.
62. Melez, K.A., Boegel, W.A. and Steinberg, A.D. 1980. Therapeutic studies in New Zealand mice. VII Successful androgen treatment of NZB/NZW F1 females of different ages. Arthritis Rheum, 23(1):41-7.
63. Mishra, N., Reilly, C., Brown, D., Ruiz, P. and Gilkeson, G. 2003. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Invest, 111(4):539-52.
64. Moriarty, K., Kim, K.H. and Bender, J.R. 2006. Mini review: estrogen receptor-mediated rapid signaling. Endocrinology, 147(12):5557-63.
65. Nossal, G.J.V. 2001. A purgative mastery. Nature, 412:685-6.
66. Quandt, D., Hoff, H., Rudolph, M., Fillatreau, S. and Brunner-Weinzierl, M.C. 2007. A new role of CTLA-4 on B cells in thymus-dependent immune responses in vivo. J. Immunol., 179(11):7316-24.
67. Rieck, M., Arechiga, A., Onengut-Gumuscu, S., Greenbaum, C., Concannon, P. and Buckner, J.H. 2007. Genetic variation in PTPN22 corresponds to altered function off and B lymphocytes. J. Immunol., 179(7):4704-10.
68. Roubinian, J.R., Talal, N., Greenspan, J.S., Goodman, J.R. and Siiteri, P.K. 1978. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J. Exp. Med., 147(6):1568-83.
69. Rubino, D., Driggers, P., Arbit D., Kemp, L., Miller, B., Coso, O., Pagliai, K., Gray, K., Gutkind, S. and Segars, J. 1998. Characterization of Brx, a novel Dbl family member that modulates estrogen receptor action. Oncogene, 16(19):2513-26.
70. Rudolph, E.H., Congdon, K.L., Sackey, F.N., Fitzsimons, M.M. and Foster, M.H. 2002. Humoral autoimmunity to basement membrane antigens is regulated in C57BL/6 and MRL/MpJ mice transgenic for antilaminin Ig receptors. J. Immunol., 168:5943-53.
71. Salvador, J.M., Hollander, M.C., Nguyen, A.T., Kopp, J.B., Barisoni, L., Moore, J.K., Ashwell, J.D. and Fornace, A.J. Jr. 2002. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity, 16(4):499-508.
72. Shachar, I., Elliott, E.A., Chasnoff, B., Grewal, I.S. and Flavell, R.A. 1995. Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforms. Immunity, 3(3):373-83.
73. Shachar, I. and Flavell, R.A. 1996. Requirement for invariant chain in B cell maturation and function. Science, 274(5284):106-8.
74. Shibolet, O., Giallourakis, C., Rosenberp, I., Mueller, T., Xavier, R.J. and Podolsky, D.K. 2007. AKAP13, a RhoA GTPase-specific guanine exchange factor, is a novel regulator of TLR2 signaling. J. Biol. Chem., 282(48):35308-17.
75. Shim, G.J., Kis, L.L., Warner, M. and Gustafsson, J.A. 2004a. Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proc. Natl. Acad. Sci. U.S.A., 101(6):1720-4.
76. Shim, G.J., Wang, L., Andersson, S., Nagy, N., Kis, L.L., Zhang, Q., Makela, S., Warner, M. and Gustafsson, J.A. 2003. Disruption of the estrogen receptor beta gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc. Natl. Acad. Sci. U.S.A., 100(11):6694-9.
77. Shim, G.J., Warner, M., Kim, H.J., Andersson, S., Liu, L., Ekman J., Imamov, O., Jones, M.E., Simpson, E.R. and Gustafsson, J.A. 2004b. Aromatase-deficient mice spontaneously develop a lymphoproliferative autaimmune disease resembling Sjogren's syndrome. Proc. Natl. Acad. Sci. U.S.A., 101(34):12628-33.
78. Siatskas, C., Chan, J., Field, J., Murphy, K., Nasa, Z., Toh, B.H. and Alderuccio, F. 2006. Gene therapy strategies towards immune tolerance to treat the autoimmune diseases. Curr. Gene Ther., 6(1):45-58.
79. Smyth, D., Cooper, J.D., Collins, J.E., Heward, J.M., Franklyn, J.A., Howson, J.M., Vella, A., Nutland, S., Rance, H.E., Maier, L. and others. 2004. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes, 53(11):3020-3.
80. Starlets, D., Gore, Y., Binsky, I., Haran, M., Harpaz, N., Shvidel, L., Becker-Herman, S., Berrebi, A. and Shachar, I. 2006. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood, 107(12):4807-16.
81. Stein, R., Mattes, M.J., Cardillo, T.M., Hansen, H.J., Chang, C.H., Burton, J., Govindan, S. and Goldenberg, D.M. 2007. CD74: a new candidate target for the immunotherapy of B-cell neoplasms. Clin. Cancer Res., 13(18(Pt(2)):5556s-5563s.
82. Steinberg, A.D., Roths, J.B., Murphy, E.D., Steinberg, R.T. and Raveche, E.S. 1980. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice. J. Immunol., 125(2):871-3.
83. Teft, W.A., Kirchhof, M.G. and Madrenas, J. 2006. A molecular perspective of CTLA-4 function. Annu Rev. Immunol., 24:65-97.
84. Ting, J.P., Kastner, D.L. and Hoffman, H.M. 2006. CATERPILLERs, pyrin and hereditary immunological disorders. Nat. Rev. Immunol., 6(3):183-95.
85. Vang, T., Congia, M., Macis, M.D., Musumeci, L., Orru, V., Zavattari, P., Nika, K., Tautz, L., Tasken, K., Cucca, F. and others. 2005. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet., 37(12):1317-9.
86. Venkatesh, J., Peeva, E., Xu, X. and Diamond, B. 2006. Cutting Edge: Hormonal milieu, not antigenic specificity, determines the mature phenotype of autoreactive B cells. J. Immunol., 176(6):3311-4.
87. Verkoczy, L.K., Guinn, B. and Berinstein, N.L. 2000. Characterization of the human B cell RAG-associated gene, hBRAG, as a B cell receptor signal-enhancing glycoprotein dimer that associates with phosphorylated proteins in resting B cells. J. Biol. Chem., 275(28):20967-79.
88. Verthelyi, D. and Ahmed, S.A. 1994. 17 beta-estradiol, but not 5 alpha-dihydrotestosterone, augments antibodies to double-stranded deoxyribonucleic acid in nonautoimmune C57BL/6J mice. Endocrinology, 135(6):2615-22.
89. Verthelyi, D.I. and Ahmed, S.A. 1998. Estrogen increases the number of plasma cells and enhances their autoantibody production in nonautoimmune C57BL/6 mice. Cell. Immunol., 189(2):125-34.
90. Viville, S., Neefjes, J., Lotteau, V., Dierich, A., Lemeur, M., Ploegh, H., Benoist C. and Mathis, D. 1993. Mice lacking the MHC class II-associated invariant chain. Cell., 72(4):635-48.
91. Wicker, L.S., Clark, J., Fraser, H.I., Garner, V.E., Gonzalez-Munoz, A., Healy, B., Howlett, S., Hunter, K., Rainbow, D., Rosa, R.L. and others. 2005. Type 1 diabetes genes and pathways shared by humans and NOD mice. J. Autoimmun, 25(Suppl):29-33.
92. Wilker, P.R., Kohyama, M., Sandau, M.M., Albring, J.C., Nakagawa, O., Schwarz, J.J. and Murphy, K.M. 2008. Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation. Nat. Immunol., 9:603-12.
93. Wolfraim, L.A. 2006. Treating autoimmune diseases through restoration of antigen-specific immune tolerance. Arch. Immunol. Ther. Erp. (Warsz), 54(1):1-13.
94. Youn, H.D., Sun, L., Prywes, R. and Liu, J.O. 1999. Apoptosis of T cells mediated by Ca2+-induced release ofthe transcription fitetor MEF2. Science, 286(5440):790-3.
95. Yu, X., Sun, J.P., He, Y, Guo, X, Liu, S:, Zhou, B., Hudmon, A. and Zhang, Z.Y. 2007. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases, Proc. Natl. Acad. Sci. U.S.A., 104(50):19767-72.